Advertisement

Topics

POLYPLUS-TRANSFECTION Company Profile

20:07 EST 18th December 2018 | BioPortfolio

Polyplus-transfection SA is focused on developing reagents for intracellular delivery of biomolecules. Its expertise includes in vitro and in vivo delivery of genes, oligonucleotides, siRNA and proteins.
Polyplus is an established, reliable partner to reseachers in academic, biotech and pharmaceutical laboratories. The company markets a complete line of reagents through an international network of yearly trained distributors.
With over half its revenues reinvested into R&D, Polyplus-transfection covers all aspects including the physical chemistry, cell biology and pharmacology of carriers. This leads to constant improvement of existing solutions as well as original compounds at the forefront of delivery science.
Further downstream, Polyplus also shares its research and experience with academic and biotech partners on the therapeutic aspects of in vivo delivery of nucleic acids.

Location

Bioparc – Boulevard Sebastien BrantBP90018
ILLKIRCH
67400
France

Contact

Phone: 33 (0)3 90 40 61 80
Fax: 33 (0)3 90 40 61 81


News Articles [12 Associated News Articles listed on BioPortfolio]

How are Polyplus Transfection addressing the challenges of delivery in RNAi therapies?

Polyplus Transfection started in 2001 to market transfection products developed in the lab of Dr Jean-Paul Behr Seminal work was published in 1989 on the use of polycationic lipids for the use of tran...

Transformative Times for Transfection: No Longer Mere Methodology, Transfection Is Being Integrated into New Applications -- http://ow.ly/1pce30mo28G pic.twitter.com/G3vR79VBrY

Transformative Times for Transfection: No Longer Mere Methodology, Transfection Is Being Integrated into New Applications -- http://ow.ly/1pce30mo28G  pic.twitter.com/G3vR79VBrY

Global Transfection Technologies Market Status and Outlook 20182025 [Report Updated: 15082018] Prices from USD $4000

Report SnapshotKey Content of Chapters Including and can be customized, report is a semifinished version, and it takes 4872 hours to upgradePart 1:Terminology Definition, Industry Chain,Industry Dynam...

PolyplusTransfection SA Pharmaceuticals Healthcare Deals and Alliances Profile [Report Updated: 09052018] Prices from USD $250

SummaryPolyplusTransfection SA Polyplus is a biotechnology company that develops and markets solutions for in vivo and in vitro delivery of nucleic acids in research, bioproduction and therapeutics. T...

No Longer Mere Methodology, Transfection Is Being Integrated into New Applications -- http://ow.ly/1pce30mo28G 

No Longer Mere Methodology, Transfection Is Being Integrated into New Applications -- http://ow.ly/1pce30mo28G 

PolyplusTransfection SA Pharmaceuticals Healthcare Deals and Alliances Profile [Report Updated: 24072018] Prices from USD $250

SummaryPolyplusTransfection SA Polyplus is a biotechnology company that develops and markets solutions for in vivo and in vitro delivery of nucleic acids in research, bioproduction and therapeutics. T...

High-yield production of human Dicer by transfection of human HEK293-EBNA1 cells grown in suspension

Dicer is a 219-kDa protein that plays key roles in gene regulation, particularly as the ribonuclease III enzyme responsible for cleaving precursor miRNA substrates. Its enzymatic activity is highly re...

Global Transfection Technologies Market 2018-2022 | Rising Demand for Monoclonal Antibodies to Boost Demand | Technavio

Technavio analysts forecast the global transfection technologies market to grow at a CAGR of almost 9% during the forecast period, according to their latest market research...

Drugs and Medications [0 Results]

None

PubMed Articles [129 Associated PubMed Articles listed on BioPortfolio]

mRNA transfection by a Xentry-protamine cell-penetrating peptide is enhanced by TLR antagonist E6446.

Messenger RNA (mRNA) transfection is a developing field that has applications in research and gene therapy. Potentially, mRNA transfection can be mediated efficiently by cell-penetrating peptides (CPP...

A comprehensive review on histone-mediated transfection for gene therapy.

Histone has been considered to be an effective carrier in non-viral gene delivery due to its unique properties such as efficient DNA binding ability, direct translocation to cytoplasm and favorable nu...

High Throughput Transfection of HEK293 Cells for Transient Protein Production.

Transient transfection of mammalian cells is used in the biotechnology industry to quickly supply recombinant protein for research and large molecule drug development. Here, we describe a method for h...

Molecular Strings Significantly Improved the Gene Transfection Efficiency of Polycations.

High transfection efficiency and low cytotoxicity are the two key factors to be considered in the design of gene carriers. Herein, a novel and versatile gene carrier (PLL-RT) was prepared by introduci...

Brazilin Induces T24 Cell Death Through c-Fos and GADD45β Independently Regulated Genes and Pathways.

Purified Brazilin from Sappan wood extract has been reported with significant antitumor effect, especially on human T24 cells and bladder cancer mouse models. Brazilin can significantly induce express...

Clinical Trials [12 Associated Clinical Trials listed on BioPortfolio]

PTEN and IGFBP-3 Correlation in Ovarian Carcinoma Invasion

We have identified insulin-like growth factor binding protein (IGFBP)-3 as an invasion suppressor gene in ovarian endometrioid carcinoma, and showed association with lower cancer migration...

Immunotherapy of Melanoma With Tumor Antigen RNA and Small Inhibitory RNA Transfected Autologous Dendritic Cells

Transfection with siRNA targeting the immunoproteasome alters proteasome-mediated antigen processing by the dendritic cell, generating TAA-derived peptides that we hypothesize, based on pr...

A Roll Over Study of Alectinib in Patients With Anaplastic Lymphoma Kinase (ALK)-Positive or Rearranged During Transfection (RET)-Positive Cancer

The purpose of this study is to provide continued treatment with alectinib or crizotinib as applicable to participants with ALK- or RET positive cancer who were previously enrolled in any ...

A Phase 1, First Time in Human (FTIH) Study to Evaluate GSK3352589, a REarranged During Transfection (RET) Growth Factor Receptor Tyrosine Kinase Inhibitor, in Healthy Volunteers

This FTIH study is designed to assess the safety, tolerability and pharmacokinetic (PK) of escalating single and repeat oral doses of GSK3352589 in normal healthy volunteers. This is a ran...

The Role of Aromatic Hydrocarbon Receptor in the Tumorigenesis of Neuroblastoma and Its Relationship With MYCN Expression

Neuroblastoma (NB) is the most common malignant tumor of infancy. Approximately 60% of NB patients are clinically diagnosed as the stage IV disease and have a very poor prognosis with the ...

Companies [17 Associated Companies listed on BioPortfolio]

POLYPLUS-TRANSFECTION

Polyplus-transfection SA is focused on developing reagents for intracellular delivery of biomolecules. Its expertise includes in vitro and in vivo delivery of genes, oligonucleotides, siRNA and protei...

Altogen Biosystems - cell transfection products

Altogen Biosystems is a life sciences company dedicated to the development, marketing and manufacture of cell type specific transfection reagents. Efficient delivery of DNA, RNA, siRNA, and microRNA e...

Altogen Biosystems

Transfection is the introduction of foreign DNA or RNA molecules into cultured cells. Transfection is now a commonly used method in biological laboratories for studying gene function, modulation of ge...

ALTOGEN LABS

Altogen Labs (www.altogenlabs.com) is a life sciences company dedicated to providing pre-clinical research services to pharmaceutical and biotechnology organizations worldwide. ...

TranXenoGen

TranXenoGen is developing transgenic technologiesfor the production of transgenic animals, includinga non-viral method for the transfection of large transgenesinto chicken eggs (Direct-Egg Transfectio...

More Information about "POLYPLUS-TRANSFECTION" on BioPortfolio

We have published hundreds of POLYPLUS-TRANSFECTION news stories on BioPortfolio along with dozens of POLYPLUS-TRANSFECTION Clinical Trials and PubMed Articles about POLYPLUS-TRANSFECTION for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of POLYPLUS-TRANSFECTION Companies in our database. You can also find out about relevant POLYPLUS-TRANSFECTION Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Collaborations in biotechnology
Commercial and academic collaborations are used throughout the biotechnology and pharmaceutical sector to enhance research and product development. Collaborations can take the form of research and evaluation agreements, licensing, partnerships etc. ...

Biotechnology - Biotech
"using living things to create products or to do tasks for humans" About Biotechnology - Biotech Biotechnology is the practice of using plants, animals and micro-organisms such as bacteria, as well as biological processes - such as the ripen...


Corporate Database Quicklinks



Searches Linking to this Company Record